O. Kizilca, R. Siraneci, A. Yilmaz, N. Hatipoglu, E. Ozturk et al., Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children, Pediatrics International, vol.7, issue.6, p.85862, 2012.
DOI : 10.1111/j.1442-200X.2012.03709.x

R. Dhillon and C. J. , ESBLs: A Clear and Present Danger?, Critical Care Research and Practice, vol.21, issue.7, p.625170, 2012.
DOI : 10.1016/j.ajic.2006.05.238

URL : http://doi.org/10.1155/2012/625170

M. Marzouk, A. Ferjani, H. Ali, M. Boukadida, and J. , Profile and susceptibility to antibiotics in urinary tract infections in children and newborns from 2012 to 2013: Data from 1879 urine cultures]. Arch Pediatr Organe Off Soc Francaise Pediatr, p.5059, 2015.

J. Zorc, D. Kiddoo, and K. Shaw, Diagnosis and Management of Pediatric Urinary Tract Infections, Clinical Microbiology Reviews, vol.18, issue.2, p.41722, 2005.
DOI : 10.1128/CMR.18.2.417-422.2005

P. Mariani-kurkdjian, C. Doit, and E. Bingen, Extended-spectrum beta-lactamase producingenterobacteriaceae] . Arch Pediatr Organe Off Soc Francaise Pediatr, nov, vol.19, pp.93-96, 2012.

J. Pitout and K. Laupland, Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern, Lancet Infect Dis. mars, vol.8, issue.3, p.15966, 2008.
DOI : 10.1016/s1473-3099(08)70041-0

V. Blanc, V. Leflon-guibout, J. Blanco, M. Haenni, J. Madec et al., Prevalence of daycare centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains, J Antimicrob Chemother. mai, vol.69, issue.5, p.12317, 2014.

A. Birgy, R. Cohen, C. Levy, P. Bidet, C. Courroux et al., Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceaein french children, BMC Infectious Diseases, vol.41, issue.5, p.315, 2012.
DOI : 10.1093/jac/dkl326

URL : http://doi.org/10.1186/1471-2334-12-315

E. Launay, E. Bingen, R. Cohen, and G. De-pathologie-infectieuse-pédiatrique, [Therapeutics strategies for the management of urinary tract infection in children]. Arch Pediatr Organe Off Soc Francaise Pediatr, nov, vol.19, issue.3, pp.109-116, 2012.

D. Fournier, C. Chirouze, J. Leroy, P. Cholley, D. Talon et al., Alternatives to carbapenems in ESBL-producing Escherichia coli infections, M??decine et Maladies Infectieuses, vol.43, issue.2, p.626, 2013.
DOI : 10.1016/j.medmal.2013.01.006

URL : https://hal.archives-ouvertes.fr/hal-00802661

. Infections-urinaires_spilf_argumentaire, docx -infections-urinaires-spilf-argumentaire.pdf [Internet]. [cité 12 nov 2016]. Disponible sur: http://www.infectiologie.com/UserFiles/File/spilf/recos/infections-urinaires-spilf-argumentaire

K. Vardakas, G. Tansarli, P. Rafailidis, and M. Falagas, Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum ??-lactamases: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, p.2793803, 2012.
DOI : 10.1093/jac/dks301

L. Rivard-yazigi, J. Zahar, L. Guillou, S. Chalouhi, C. Lecuyer et al., Risk factors associated with extended-spectrum ??-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France, American Journal of Infection Control, vol.41, issue.9, p.8445, 2013.
DOI : 10.1016/j.ajic.2012.11.016

J. Oteo, M. Pérez-vázquez, and J. Campos, Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact, Curr Opin Infect Dis. août, vol.23, issue.4, p.3206, 2010.
DOI : 10.1097/qco.0b013e3283398dc1

G. Peirano and J. Pitout, Molecular epidemiology of Escherichia coli producing CTX-M betalactamases: the worldwide emergence of clone ST131 O25:H4, Int J Antimicrob Agents. avr, vol.35, issue.4, p.31621, 2010.

C. Arpin, C. Quentin, F. Grobost, E. Cambau, J. Robert et al., Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting, J Antimicrob Chemother. juin, vol.63, issue.6, p.120514, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00426312

S. Bontemps, M. Lagrée, R. Dessein, A. Maftei, A. Martinot et al., [Management of urinary tract infections in children. Evaluation of clinical practice]. Arch Pediatr Organe Off Soc Francaise Pediatr, janv, vol.22, issue.1, p.2431, 2015.

Z. Özçakar, F. Yalç?nkaya, A. Kavaz, G. Kad?olu, A. Elhan et al., Urinary tract infections owing to ESBL-producing bacteria: microorganisms change - clinical pattern does not, Acta Paediatrica, vol.122, issue.8, pp.61-64, 1992.
DOI : 10.1111/j.1651-2227.2011.02262.x

C. Lee, C. Chu, J. Liu, Y. Chen, C. Chiu et al., Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 ??-lactamases, Journal of Antimicrobial Chemotherapy, vol.60, issue.2, p.4103, 2007.
DOI : 10.1093/jac/dkm215

J. Lin, Y. Chen, L. Chang, C. Lai, H. Lin et al., Clinical characteristics and outcomes of patients with extended-spectrum ??-lactamase-producing bacteremias in the emergency department, Internal and Emergency Medicine, vol.51, issue.Suppl 1, p.54755, 2011.
DOI : 10.1007/s11739-011-0707-3

D. Vodovar, G. Marcadé, L. Raskine, I. Malissin, and B. Mégarbane, Enterobacteriaceae producing extended spectrum beta-lactamase: epidemiology, risk factors, and prevention], Rev Med Interne. nov, vol.34, issue.11, p.68793, 2013.

J. Lee, I. Bae, and S. Lee, New definitions of extended-spectrum ??-lactamase conferring worldwide emerging antibiotic resistance, Medicinal Research Reviews, vol.289, issue.1, p.21632, 2012.
DOI : 10.1002/med.20210

D. Hoban, C. Lascols, L. Nicolle, R. Badal, S. Bouchillon et al., Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study, Diagn Microbiol Infect Dis. sept, vol.74, issue.1, p.627, 2009.

P. Lu, Y. Liu, H. Toh, Y. Lee, Y. Liu et al., Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009???2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), International Journal of Antimicrobial Agents, vol.40, pp.37-43, 2012.
DOI : 10.1016/S0924-8579(12)70008-0

J. Toubiana, S. Timsit, A. Ferroni, M. Grasseau, X. Nassif et al., Community-Onset Extended-Spectrum ??-Lactamase???Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France, Medicine, vol.95, issue.12, p.3163, 2016.
DOI : 10.1097/MD.0000000000003163

J. Rex and M. Pfaller, Has antifungal susceptibility testing come of age? Clin Infect Dis Off Publ Infect Dis Soc Am, 15 oct, vol.35, issue.8, p.9829, 2002.

. Recommandations-de-la-société-française-de-microbiologie, sfm-microbiologie.org/UserFiles/files

J. Rodríguez-baño, M. Navarro, P. Retamar, E. Picón, and Á. Pascual, Extended-Spectrum Beta- Lactamases?Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. -Lactam/-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum -lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts, Clin Infect Dis Off Publ Infect Dis Soc Am. 15 janv, vol.54, issue.2, p.16774, 2012.

J. Lee, H. Pai, Y. Kim, N. Kim, B. Eun et al., Control of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy, J Antimicrob Chemother. sept, vol.60, issue.3, p.62937, 2007.